Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Nuclear FAM289-Galectin-1 interaction controls FAM289-mediated tumor promotion in malignant glioma.

Guo XR, Wu MY, Dai LJ, Huang Y, Shan MY, Ma SN, Wang J, Peng H, Ding Y, Zhang QF, Tang JM, Ruan XZ, Li DS.

J Exp Clin Cancer Res. 2019 Sep 6;38(1):394. doi: 10.1186/s13046-019-1393-7.

2.

Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.

Chung LY, Tang SJ, Sun GH, Chou TY, Yeh TS, Yu SL, Sun KH.

Clin Cancer Res. 2012 Aug 1;18(15):4037-47. Epub 2012 Jun 13.

3.

The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.

Luo D, Xu X, Li J, Chen C, Chen W, Wang F, Xie Y, Li F.

Int J Oncol. 2018 Nov;53(5):2067-2080. doi: 10.3892/ijo.2018.4525. Epub 2018 Aug 14.

PMID:
30106127
4.

Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.

Jung TY, Jung S, Ryu HH, Jeong YI, Jin YH, Jin SG, Kim IY, Kang SS, Kim HS.

J Neurosurg. 2008 Aug;109(2):273-84. doi: 10.3171/JNS/2008/109/8/0273.

PMID:
18671640
5.

TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Di K, Linskey ME, Bota DA.

Oncogene. 2013 Oct 17;32(42):5038-47. doi: 10.1038/onc.2012.531. Epub 2012 Nov 26.

6.

Role of glycosyltransferase PomGnT1 in glioblastoma progression.

Lan J, Guo P, Lin Y, Mao Q, Guo L, Ge J, Li X, Jiang J, Lin X, Qiu Y.

Neuro Oncol. 2015 Feb;17(2):211-22. doi: 10.1093/neuonc/nou151. Epub 2014 Aug 1.

7.

Exogenous IGFBP-2 promotes proliferation, invasion, and chemoresistance to temozolomide in glioma cells via the integrin β1-ERK pathway.

Han S, Li Z, Master LM, Master ZW, Wu A.

Br J Cancer. 2014 Sep 23;111(7):1400-9. doi: 10.1038/bjc.2014.435. Epub 2014 Aug 5.

8.
9.

Molecular and clinical characterization of Galectin-9 in glioma through 1,027 samples.

Yuan F, Ming H, Wang Y, Yang Y, Yi L, Li T, Ma H, Tong L, Zhang L, Liu P, Li J, Lin Y, Yu S, Ren B, Yang X.

J Cell Physiol. 2019 Oct 14. doi: 10.1002/jcp.29309. [Epub ahead of print]

PMID:
31609000
10.

Downregulation of RNF138 inhibits cellular proliferation, migration, invasion and EMT in glioma cells via suppression of the Erk signaling pathway.

Wu H, Li X, Feng M, Yao L, Deng Z, Zao G, Zhou Y, Chen S, Du Z.

Oncol Rep. 2018 Dec;40(6):3285-3296. doi: 10.3892/or.2018.6744. Epub 2018 Sep 28.

11.

20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.

Chen Z, Wei X, Shen L, Zhu H, Zheng X.

Cancer Sci. 2019 Jan;110(1):389-400. doi: 10.1111/cas.13881. Epub 2018 Dec 14.

12.

Binding of galectin-1 to integrin β1 potentiates drug resistance by promoting survivin expression in breast cancer cells.

Nam K, Son SH, Oh S, Jeon D, Kim H, Noh DY, Kim S, Shin I.

Oncotarget. 2017 May 30;8(22):35804-35823. doi: 10.18632/oncotarget.16208.

13.

Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.

Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.

Mol Pharm. 2018 Nov 5;15(11):4912-4925. doi: 10.1021/acs.molpharmaceut.8b00551. Epub 2018 Oct 17.

PMID:
30336060
14.

The CHAC1-inhibited Notch3 pathway is involved in temozolomide-induced glioma cytotoxicity.

Chen PH, Shen WL, Shih CM, Ho KH, Cheng CH, Lin CW, Lee CC, Liu AJ, Chen KC.

Neuropharmacology. 2017 Apr;116:300-314. doi: 10.1016/j.neuropharm.2016.12.011. Epub 2016 Dec 13.

PMID:
27986595
15.

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.

Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK.

Neuro Oncol. 2013 May;15(5):562-77. doi: 10.1093/neuonc/not005. Epub 2013 Feb 26.

16.

Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway.

Peng Y, He X, Chen H, Duan H, Shao B, Yang F, Li H, Yang P, Zeng Y, Zheng J, Li Y, Hu J, Lin L, Teng L.

Biosci Rep. 2018 Sep 12;38(5). pii: BSR20181051. doi: 10.1042/BSR20181051. Print 2018 Oct 31.

17.

Transcriptional repression of Mad-Max complex by human umbilical cord blood stem cells downregulates extracellular signal-regulated kinase in glioblastoma.

Velpula KK, Dasari VR, Tsung AJ, Dinh DH, Rao JS.

Stem Cells Dev. 2012 Jul 1;21(10):1779-93. doi: 10.1089/scd.2011.0424. Epub 2011 Nov 21. Erratum in: Stem Cells Dev. 2013 May 15;22(10):1624.

18.

Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis.

Bota DA, Alexandru D, Keir ST, Bigner D, Vredenburgh J, Friedman HS.

J Neurosurg. 2013 Dec;119(6):1415-23. doi: 10.3171/2013.7.JNS1323. Epub 2013 Oct 4.

19.

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.

Zhang P, Zhang P, Shi B, Zhou M, Jiang H, Zhang H, Pan X, Gao H, Sun H, Li Z.

Cell Death Dis. 2014 Jan 9;5:e991. doi: 10.1038/cddis.2013.526.

20.

DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.

Zhou D, Wan Y, Xie D, Wang Y, Wei J, Yan Q, Lu P, Mo L, Xie J, Yang S, Qi X.

Exp Mol Med. 2015 Sep 4;47:e182. doi: 10.1038/emm.2015.57.

Supplemental Content

Support Center